Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1073_Библиотеки_им_академика_М_И_Перельмана
.pdf
37 Deciding onanIRA vs. IPAA forFAP
https://t.me/medicina_free
419
Personal View oftheData
When patients with FAP need an operation, the decision for proctocolectomy with
IPAA or end ileostomy, or preservation of the rectum with IRA, is guided largely by
the anticipated oncological and functional outcomes related to each operation. It is
important that the surgeon and patient to recognize that one operation does not t all
FAP patients: some need more (IPAA or end ileostomy) and others will do better
with less (IRA).
FAP patients with <1000 colorectal adenomas, <20 rectal adenomas, and no
colon or rectal cancer, should do well with an IRA.This is a relatively simple operation, without need for a diverting ileostomy, less postoperative complications, and
more favorable functional outcomes compared to IPAA.Alternatively, in patients
with >1000 colorectal adenomas, or more than 20 rectal adenomas, or colon or
(particularly) rectal cancer, or high-risk for desmoid tumor formation, proctocolectomy with IPAA or end ileostomy are often better surgical options.
The decision on IPAA or end ileostomy involves consideration of the patients’
base-line anal sphincter function (e.g., their ability to defer defecation), their preference for one operation versus another, and an assessment of the anticipated complexity of the planned surgical procedure. For example, in the obese, male FAP
patient, with distal rectal high-grade dysplasia or cancer, for whom mucosectomy
with sutured IPAA may be the ideal cancer-preventing operation, it may be technically impossible to perform due to the inability of an ileal pouch to reach to the mid
anal canal. The decision on stapled or hand sewn IPAA (with distal rectal mucosectomy) also warrants consideration of the outcomes of each approach as more favorable functional outcomes are expected with a stapled IPAA and no guarantee against
rectal remnant cancer development even after mucosectomy.
When proctocolectomy is indicated, the option of a permanent end ileostomy
may be preferable for some patients who have considered the pros and cons of each
operation. For example, with an IPAA, 5–7 bowel movements per day and 1–2 that
awaken the patient from sleep, should be expected. This frequency of bowel movements may be unacceptable to some patients who may then choose an end ileostomy. Finally, in the young female patient, with say hundreds of colon adenomas or
20–30 rectal adenomas without high-grade dysplasia or cancer, a staged approach,
starting with IRA, then annual rectal endoscopic surveillance, and eventual proctectomy, as needed, may be the best strategy to prevent cancer while also limiting
interference with pregnancy and childbirth.
References
1. Aretz S, Uhlhaas S, Caspari R, etal. Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet. 2004;12(1):52–8. https://doi.
org/10.1038/sj.ejhg.5201088.
2. Olkinuora AP, Peltomäki PT, Aaltonen LA, Rajamäki K.From APC to the genetics of hereditary and familial colon cancer syndromes. Hum Mol Genet. 2021;30(R2):R206–24. https://
doi.org/10.1093/hmg/ddab208.

420
https://t.me/medicina_free
3. Björk J, Åkerbrant H, Iselius L, etal. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology.
2001;121(5):1127–35. https://doi.org/10.1053/gast.2001.28707.
4. Herzig D, Hardimann K, Weiser M, etal. The American Society of Colon and Rectal Surgeons
clinical practice guidelines for the management of inherited polyposis syndromes. Dis Colon
Rectum. 2017;60(9):881–94. https://doi.org/10.1097/DCR.0000000000000912.
5. Bülow S, Bülow C, Vasen H, Järvinen H, Björk J, Christensen IJ.Colectomy and ileorectal
anastomosis is still an option for selected patients with familial adenomatous polyposis. Dis
Colon Rectum. 2008;51(9):1318–23. https://doi.org/10.1007/s10350- 008- 9307- 3.
6. Koskenvuo L, Mustonen H, Renkonen-Sinisalo L, Järvinen HJ, Lepistö A.Comparison of
proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in
familial adenomatous polyposis. Familial Cancer. 2015;14(2):221–7. https://doi.org/10.1007/
s10689- 014- 9773- 9.
7. Soravia C, Klein L, Berk T, O’Connor B, Cohen Z, McLeod RS.Comparison of ileal pouchanal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis.
Dis Colon Rectum. 1999;42(8):1028–33.
8. Campos FG, Perez RO, Imperiale AR, Seid VE, Nahas SC, Cecconello I.Surgical treatment
of familial adenomatous polyposis: Ileoretal anastomosis or restorative proctolectomy? Arq
Gastroenterol. 2009;46(4):294–9. https://doi.org/10.1590/S0004- 28032009000400009.
9. Ambroze WL, Dozois RR, Pemberton JH, Beart RW, Ilstrup DM.Familial adenomatous polyposis: results following ileal pouch-anal anastomosis and ileorectostomy. Dis Colon Rectum.
1992;35(1):12–5. https://doi.org/10.1007/BF02053332.
10. Tonelli F, Valanzano R, Monaci I, Mazzoni P, Anastasi A, Ficari F.Restorative proctocolectomy or rectum-preserving surgery in patients with familial adenomatous polyposis: results of
a prospective study. World J Surg. 1997;21(6):653–9. https://doi.org/10.1007/s002689900289.
11. Van Duijvendijk P, Slors JFM, Taat CW, etal. Quality of life after total colectomy with ileorectal anastomosis or proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous
polyposis. Br J Surg. 2000;87(5):590–6. https://doi.org/10.1046/j.1365- 2168.2000.01442.x.
12. Björk J, Åkerbrant H, Iselius L, etal. Outcome of primary and secondary ileal pouch-anal
anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis
Colon Rectum. 2001;44(7):984–92. https://doi.org/10.1007/BF02235487.
13. Konishi T, Ishida H, Ueno H, etal. Feasibility of laparoscopic total proctocolectomy with ileal
pouch–anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study. Int J Clin Oncol. 2016;21(5):953–61.
https://doi.org/10.1007/s10147- 016- 0977- x.
14. Mozafar M, Shateri K, Tabatabaey A, Lotfollahzadeh S, Atqiaee K.Familial adenomatous
polyposis: Ileo-anal pouch versus ileo-rectal anastomosis. Gastroenterol Hepatol Bed Bench.
2014;7(4):206–10.
15. Hassan I, Chua HK, Wolff BG, etal. Quality of life after ileal pouch-anal anastomosis and
ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum.
2005;48(11):2032–7. https://doi.org/10.1007/s10350- 005- 0169- 7.
16. Ko CY, Rusin LC, Schoetz DJ, etal. Does better functional result equate with better quality of life? Implications for surgical treatment in familial adenomatous polyposis. Dis Colon
Rectum. 2000;43(6):829–37. https://doi.org/10.1007/bf02238022.
17. Madden MV, Neale KF, Nicholls RJ, etal. Comparison of morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous
polyposis. Br J Surg. 2005;78(7):789–92.
18. Aziz O, Athanasiou T, Fazio VW, et al. Meta-analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg.
2006;93(4):407–17. https://doi.org/10.1002/bjs.5276.
19. Hartley JE, Church JM, Gupta S, McGannon E, Fazio VW, Phillips RKS. Signicance of
incidental desmoids identied during surgery for familial adenomatous polyposis. Dis Colon
Rectum. 2004;47(3):334–40. https://doi.org/10.1007/s10350- 003- 0063- 0.
S. H. Lai and J. D. Vogel

37 Deciding onanIRA vs. IPAA forFAP
https://t.me/medicina_free
20. Nieuwenhuis MH, Lefevre JH, Bülow S, etal. Family history, surgery, and APC mutation are
risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study.
Dis Colon Rectum. 2011;54(10):1229–34. https://doi.org/10.1097/DCR.0b013e318227e4e8.
21. Sommovilla J, Liska D, Jia X, etal. Ileal Pouch anal anastomosis is more “Desmoidogenic”
than ileorectal anastomosis in familial adenomatous polyposis. Dis Colon Rectum. 2021;
Publish Ah:1351–1361. https://doi.org/10.1097/dcr.0000000000002172.
22. Burgess A, Xhaja X, Church J.Does intra-abdominal desmoid disease affect patients with
an ileal pouch differently than those with an ileorectal anastomosis? Dis Colon Rectum.
2011;54(11):1388–91. https://doi.org/10.1097/DCR.0b013e31822f8d91.
23. Vasen HFA, Möslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57(5):704–13. https://doi.org/10.1136/
gut.2007.136127.
24. Vogel J, Church JMLL.Minimally invasive pouch surgery predisposes to desmoid tumor formation in patients with familial adenomatous polyposis. Dis Colon Rectum. 2005;48:662.
25. Saito Y, Hinoi T, Ueno H, etal. Risk factors for the development of Desmoid tumor after colectomy in patients with familial adenomatous polyposis: multicenter retrospective cohort study
in Japan. Ann Surg Oncol. 2016;23:559–65. https://doi.org/10.1245/s10434- 016- 5380- 3.
26. Walter T, Zhenzhen Wang C, Guillaud O, et al. Management of desmoid tumours: a large
national database of familial adenomatous patients shows a link to colectomy modalities and
low efcacy of medical treatments. United Eur Gastroenterol J. 2017;5(5):735–41. https://doi.
org/10.1177/2050640616678150.
27. Da Luz MA, Church JM, Burke CA.The evolution of prophylactic colorectal surgery for familial adenomatous polyposis. Dis Colon Rectum. 2009;52(8):1481–6. https://doi.org/10.1007/
DCR.0b013e3181ab58fb.
28. Xie M, Chen Y, Wei W, et al. Does ileoanal pouch surgery increase the risk of desmoid in
patients with familial adenomatous polyposis? Int J Color Dis. 2020;35(8):1599–605. https://
doi.org/10.1007/s00384- 020- 03578- y.
29. Fábio GC.Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. World J Gastroenterol. 2014;20(44):16620–9. https://doi.org/10.3748/wjg.
v20.i44.16620.
30. Church J, Burke C, McGannon E, Pastean O, Clark B.Risk of rectal cancer in patients after
colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of
available surgical options. Dis Colon Rectum. 2003;46(9):1175–81. https://doi.org/10.1007/
s10350- 004- 6710- 2.
31. Sinha A, Tekkis PP, Rashid S, Phillips RKS, Clark SK.Risk factors for secondary proctectomy
in patients with familial adenomatous polyposis. Br J Surg. 2010;97(11):1710–5. https://doi.
org/10.1002/bjs.7202.
32. Bülow C, Vasen H, Järvinen H, Björk J, Bisgaard ML, Bülow S.Ileorectal anastomosis is
appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology.
2000;119(6):1454–60. https://doi.org/10.1053/gast.2000.20180.
33. Koskenvuo L, Renkonen-Sinisalo L, Järvinen HJ, Lepistö A.Risk of cancer and secondary
proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis. Int
J Color Dis. 2014;29(2):225–30. https://doi.org/10.1007/s00384- 013- 1796- 4.
34. Debinski HS, Love S, Spigelman AD, Phillips RKS.Colorectal polyp counts and cancer
risk in familial adenomatous polyposis. Gastroenterology. 1996;110(4):1028–30. https://doi.
org/10.1053/gast.1996.v110.pm8612989.
35. Wu JS, Paul P, McGannon EA, Church JM. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg. 1998;227(1):57–62. https://doi.
org/10.1097/00000658- 199801000- 00009.
36. Church J, Burke C, McGannon E, Pastean O, Clark B, Cohen Z.Predicting polyposis severity by proctoscopy: how reliable is it? Dis Colon Rectum. 2001;44(9):1249–52. https://doi.
org/10.1007/bf02234779.
37. Talseth-Palmer BA.The genetic basis of colonic adenomatous polyposis syndromes. Hered
Cancer Clin Pract. 2017;15(1):1–7. https://doi.org/10.1186/s13053- 017- 0065- x.
421

422
https://t.me/medicina_free
38. Nieuwenhuis MH, Mathus-Vliegen LM, Slors FJ, etal. Genotype-phenotype correlations as
a guide in the management of familial adenomatous polyposis. Clin Gastroenterol Hepatol.
2007;5(3):374–8. https://doi.org/10.1016/j.cgh.2006.12.014.
39. Church JM. Controversies in the surgery of patients with familial adenomatous polyposis and lynch syndrome. Familial Cancer. 2016;15(3):447–51. https://doi.org/10.1007/
s10689- 016- 9886- 4.
40. Möslein G.Surgical considerations in FAP-related pouch surgery: could we do better? Familial
Cancer. 2016;15(3):457–66. https://doi.org/10.1007/s10689- 016- 9904- 6.
41. Van Duijvendijk P, JFM S, Taat CW, Oosterveld P.Functional outcome after colectomy and
ileorectal anastomosis compared with proctocolectomy and ileal pouch anal anastomosis in
familial adenomatous polyposis. Ann Surg. 1999;230(5):648–54.
42. Olsen K, Juul S, Bülow S, etal. Female fecundity before and after operation for familial
adenomatous polyposis. Br J Surg. 2003;90(2):227–31. https://doi.org/10.1002/bjs.4082.
43. Rajaratnam SG, Eglinton TW, Hider P, Fearnhead NS.Impact of ileal pouch-anal anastomosis
on female fertility: meta-analysis and systematic review. Int J Color Dis. 2011;26(11):1365–74.
https://doi.org/10.1007/s00384- 011- 1274- 9.
44. Melnitchouk N, Saadat LV, Bleday R, Goldberg JE. A decision analysis for rectal-sparing
familial adenomatous polyposis: total colectomy with Ileorectal anastomosis versus proctocolectomy with IPAA. Dis Colon Rectum. 2019;62(1):27–32. https://doi.org/10.1097/
DCR.0000000000001186.
45. Dossa F, Morris AM, Wilson AR, Baxter NN.Life after surgery: surgeon assessments of
quality of life among patients with familial adenomatous polyposis. Dis Colon Rectum.
2018;61(10):1217–22. https://doi.org/10.1097/DCR.0000000000001146.
46. Kuruvilla K, Osler T, Hyman NH.A comparison of the quality of life of ulcerative colitis patients after IPAA vs ileostomy. Dis Colon Rectum. 2012;55(11):1131–7. https://doi.
org/10.1097/DCR.0b013e3182690870.
47. Murphy PB, Khot Z, Vogt KN, Ott M, Dubois L.Quality of life after total proctocolectomy
with ileostomy or IPAA: a systematic review. Dis Colon Rectum. 2015;58(9):899–908. https://
doi.org/10.1097/DCR.0000000000000418.
48. Seidel S, Newman M, Sharp K.Ileoanal pouch versus ileostomy: is there a difference in quality of life? Am Surg. 2000;66(6):540–6.
S. H. Lai and J. D. Vogel

Rectal Prolapse: Rectopexy vs Perineal
https://t.me/medicina_free
Proctosigmoidectomy
SarahA.Vogler andKristenA.Ban
Introduction
Surgical options to treat rectal prolapse include abdominal and perineal approaches.
Abdominal approaches include resection, suture, and mesh rectopexy. Suture rectopexy can be performed with or without resection of the sigmoid colon and employs
an anterior, posterior, or circumferential mobilization of the rectum. Mesh rectopexy is typically performed with a ventral or anterior dissection. Increasingly,
abdominal repairs are performed with a minimally invasive laparoscopic or robotic
approach. Perineal approaches to treat rectal prolapse include perineal proctosigmoidectomy, also known as the Altemeier procedure, as well as the Delorme
procedure.
Historically, the abdominal approach was favored due to the lower risk of recurrence, with the perineal approach reserved for high-risk surgical candidates including the elderly or those with signicant comorbidities. In recent decades, the
incidence of abdominal surgeries has increased, while the number of perineal surgeries has decreased. This is reective of minimally invasive surgical (MIS) techniques offering ease of tolerance, acceptable outcomes, and rapid recovery even for
high-risk surgical candidates. Numerous factors impact procedure choice, including
overall health of the patient, gender, prior surgical history, symptoms, and presence
of concomitant prolapse in other pelvic compartments.
38
S. A. Vogler (*)
Cleveland Clinic Florida, Martin Health, Port St Lucie, FL, USA
e-mail: voglers@ccf.org
K. A. Ban
Cleveland Clinic Foundation, Cleveland, OH, USA
e-mail: bank4@ccf.org
© The Author(s), under exclusive license to Springer Nature
Switzerland AG 2023
K. Umanskiy, N. Hyman (eds.), Difcult Decisions in Colorectal Surgery,
Difcult Decisions in Surgery: An Evidence-Based Approach,
https://doi.org/10.1007/978-3-031-42303-1_38
423

424
https://t.me/medicina_free
S. A. Vogler and K. A. Ban
One challenge in assessing the surgical literature on rectal prolapse repair is the
paucity of adequately powered level 1 data. Additionally, there is heterogeneity
among studies comparing the abdominal versus perineal approach as within each
category there are multiple surgical options. Kim etal. note that “the myriad of
methods available to correct the underlying anatomic defects in complete rectal
prolapse poses a perplexing question for the surgeon, i.e. the choice of an ideal
operation.” [1] The objective of this review is to compare the various rectal prolapse
repair surgeries and outcomes including morbidity, recurrence, functional, and
quality of life.
Search Strategy
A search was performed using search terms dened by the PICO model outlined in
Table38.1. The population of interest was patients with rectal prolapse undergoing
rectopexy and the comparator was patients undergoing perineal proctosigmoidectomy. Outcomes of interest included recurrence of rectal prolapse, functional outcomes, quality of life, morbidity, and mortality.
PubMed was searched for relevant studies including systematic reviews (SR) and
meta-analyses (MA). The following keywords were employed: “rectal prolapse”,
“procidentia”, “rectopexy”, “perineal proctosigmoidectomy”, “perineal proctectomy”, “Altemeier”, “Delorme”. All articles identied during the initial search were
screened. The references of relevant articles were reviewed to identify additional
studies. Inclusion criteria for consideration included publication in English, adult (>
age 18) human subjects, and a study population of more than 20 patients.
Table 38.1 PICO model
Patient Population
Patients with rectal
prolapse
Intervention Comparator
Rectopexy
Perineal
proctosigmoidectomy
Outcomes
Recurrence
Functional
outcomes
Quality of life
Morbidity
Mortality

38 Rectal Prolapse: Rectopexy vs Perineal Proctosigmoidectomy
https://t.me/medicina_free
425
Results
Abdominal Versus Perineal Approach
Data comparing outcomes after abdominal compared to perineal rectal prolapse
repair come from four recent randomized trials and retrospective reviews of singleinstitution experiences.
The PROSPER trial was an international, multicenter, pragmatic, factorial study
that randomized 293 patients to abdominal (suture vs. resection rectopexy) vs. perineal (Altemeier vs. Delorme) rectal prolapse procedures and controlled for age,
ASA status and preoperative bowel function [2]. Median follow-up was 3years. A
more recent multicenter, factorial randomized trial reported by Smedberg et al.
recruited 134 patients who underwent the same four procedures [3]. Recurrence was
determined at 3years. Both studies were underpowered and neither study included
ventral mesh rectopexy (VMR). Deen etal. reported a randomized trial allocating
20 total patients to abdominal resection rectopexy and pelvic oor repair versus
perineal proctosigmoidectomy with median follow-up of 17months [4]. Emile etal.
randomized 50 patients to laparoscopic ventral mesh rectopexy versus Delorme
with a median follow-up of 18 months [5]. A high percentage of patients were
male (38%).
Kim etal. at the University of Minnesota reported one of the largest retrospective
reviews over 19years of rectal prolapse repairs performed on 372 patients [1]. 183
underwent perineal proctosigmoidectomy, 161 underwent resection rectopexy, 11
underwent Delorme, and the remaining underwent partial colectomies or anterior
resections. Patients who underwent perineal procedures were signicantly older and
sicker and had shorter recurrence-free survival. A long-term retrospective review by
Ng etal. in Australia evaluated 157 patients undergoing surgical prolapse repair,
including 44 patients who underwent resection rectopexy, 38 who underwent rectopexy, 55 who underwent Delorme, and 20 who underwent Altemeier with median
follow-up of 4.5years [6]. Patients who underwent perineal procedures were signicantly older with a mean age of 80 compared to 67years in the abdominal cohort
(p=0.001). Hu etal. compared laparoscopic ventral mesh rectopexy and perineal
repair specically in men with a median follow-up of 48.5months [7].
Morbidity
The PROSPER trial reported higher morbidity in the perineal group compared to
the abdominal group [2]. Four mortalities were reported following perineal procedures, and one mortality was reported following an abdominal procedure. Four serious morbidities were reported in the perineal group, all anastomotic leakages
following Altemeier operations, and no serious morbidities were reported in the
abdominal group. The 4-arm randomized trial reported by Smedberg described
higher complications in the perineal group than the abdominal group (3 total versus
none), but this difference was not signicant (p= 0.314) [3]. Hospital stay was

426
https://t.me/medicina_free
signicantly longer in the abdominal versus perineal cohort (mean 8days versus
5days, p=0.022). Deen etal. reported higher morbidity in the resection rectopexy
group with 2 ileus, one wound infection, and one anastomotic stricture [4]. Emile
etal. reported no major morbidity or mortality in either group [5].
Kim etal. reported similar overall complication rates in the abdominal and perineal cohorts, though the complications differed in the two groups [1]. Small bowel
obstruction was the most common complication after an abdominal procedure
(21/176 patients), but was not reported in any patient undergoing a perineal procedure. Patients undergoing perineal procedures reported higher numbers of urinary,
cardiac, and anastomotic complications than in the abdominal cohort. Ng et al.
found that morbidity was higher in the perineal cohort (17.1%) compared to abdominal (10.7%), though the difference was not signicant [6]. The Altemeier procedure
carried the highest morbidity (20%) followed by resection rectopexy (18%), rectopexy alone (16%), and Delorme (7%). In the male study population described by Hu
etal., no mortalities were reported, and complication rates were signicantly lower
after ventral mesh rectopexy (0%) compared to perineal repair (20.7%) (p=0.031) [7].
S. A. Vogler and K. A. Ban
Recurrence
The PROSPER trial did not report any signicant differences in recurrence rates
between abdominal versus perineal approaches or between different procedures in
the same approach category [2]. Reported recurrence among randomized patients
was 20% in the perineal group compared to 26% in the abdominal group (p=0.8).
Reported recurrence for all patients, including those who did not undergo intended
procedure, was 24% after Altemeier, 31% after Delorme, 13% after resection rectopexy, and 26% after suture rectopexy. Smedberg etal. reported 3-year recurrence
rates favoring the abdominal approach that were not signicant [3]. Recurrence
after suture rectopexy was 21%, after resection rectopexy 10%, after Delorme 58%,
and after Altemeier 50%. Deen etal. reported no recurrence after resection rectopexy and one recurrence after Altemeier, which was not statistically signicant [4].
Emile etal. reported higher recurrence following Delorme (16%) compared to ventral mesh rectopexy (8%), but the difference was not signicant (p=0.66) [5]. None
of the studies reported above were adequately powered to detect differences in
recurrence.
Kim etal. reported signicantly lower recurrence after abdominal (5%) versus
perineal (16%) procedures (p= 0.002) [1]. Ng et al. reported signicantly lower
recurrence rates in their abdominal operation cohort and found that perineal versus
abdominal surgical approach independently predicted recurrence in Cox regression
analysis [6]. 5-year recurrence was highest after Delorme (52%), followed by
Altemeier (30%), rectopexy (5%), and lowest after resection rectopexy (3%). Hu
etal. reported signicantly lower recurrence in men following ventral mesh rectopexy (9.5%) versus perineal repair (41.7%) (p=0.018) with median follow-up of
48.5months [7].

38 Rectal Prolapse: Rectopexy vs Perineal Proctosigmoidectomy
https://t.me/medicina_free
427
Function andQuality ofLife
The PROSPER trial reported similar signicant functional and quality of life
improvements following all procedures evaluated that were maintained at 3-year
follow-up without signicant differences between groups [2]. Fecal incontinence
measured by the Vaizey score, bowel function measured by the bowel thermometer,
and quality of life measured by the EQ-5D all improved after surgery. Smedberg
etal. reported improvements in Wexner and RAND-36 scores after all procedures
without signicant differences between procedures [3]. In the perineal procedure
cohort, Deen etal. reported signicantly higher residual fecal incontinence (FI) (OR
13.5) and signicantly lower maximum resting and squeeze pressures on manometry (p=0.003) [4]. Constipation and global quality of life scores were not reported.
Emile etal. reported similar postoperative improvement in bleeding, fecal incontinence, constipation, Wexner constipation and incontinence scores, Gastrointestinal
Quality of Life Index (GIQoL), and Fecal Incontinence Quality of Life (FIQL)
scores after both Delorme and ventral mesh rectopexy [5]. Improvements in anal
manometry measurements were also similar in both groups.
Kim etal. reported similar improvement in fecal incontinence, constipation, and
overall satisfaction following both abdominal and perineal procedures [1]. In a male
population, Hu etal. reported only perineal repair signicantly improved constipation (p=0.001) with an improvement from 72% preop to 25% postop [7]. No sexual
dysfunction was reported in either group.
Robotic Versus Laparoscopic Abdominal Approach
The highest volume of literature comparing minimally invasive surgical approaches
pertains to ventral mesh rectopexy. Four recent SRs and three MAs compare robotic
and laparoscopic ventral mesh rectopexy outcomes. Bao etal. found 14 observational
studies with over 750 patients assessing the safety and efcacy of laparoscopic and
robotic ventral mesh rectopexy [8]. Follow-up was variable, from 1months to 5years.
Operative time was longer in the robotic population, but hospital length of stay was
shorter. All studies captured in the SR by Albayati etal. were included in the larger
analysis by Bao and colleagues [9]. Emile etal. performed SR and MA of outcomes
following laparoscopic ventral mesh rectopexy and performed meta-regression analysis of predictors of recurrence [10]. The MA included 17 studies and 1242 patients
with a median follow-up of 23months. Flynn etal. found six studies meeting inclusion criteria [11], all of which were also included in the Bao SR and MA.In total, the
studies included 382 patients with follow-up ranging from 1month to almost 5years.
Morbidity
Bao etal. in their MA reported fewer conversions to open in the robotic compared
to laparoscopic populations, though this difference was not statistically signicant
[8]. The robotic approach had a signicantly lower mean intraoperative blood loss

428
https://t.me/medicina_free
(weighted mean difference −20.69, 95% CI −35.74 to −5.63, p=0.007). Robotic
ventral mesh rectopexy had signicantly lower post-operative complications (OR
0.45, 95% CI 0.24–0.83, p= 0.009). The review by Emile etal. reported pooled
outcomes after laparoscopic VMR, including a conversion to open rate of 1.8% and
a complication rate of 12.4%, primarily driven by urinary tract infection, urinary
retention, with rare reports of urethral injury, bladder injury, and vas deferens injury
in male patients [10]. Mesh-related complications were reported in less than 1% of
patients.
Flynn etal. reported no signicant difference in complications (pooled OR in
favor of robotic surgery 0.74, 95% CI 0.35–1.56) or conversion to open (pooled OR
1.09, 95% CI 0.28–4.20) [11]. Robotic VMR had a trend toward longer operative
times (pooled SMD 0.39 favoring laparoscopic, 95% CI −0.43–1.22) and signicantly shorter length of stay (pooled SMD −0.42, 95% CI −0.67–0.17).
S. A. Vogler and K. A. Ban
Recurrence
Bao et al. reported no statistically signicant difference recurrence between the
robotic and laparoscopic populations, including after sensitivity analysis [8].
Follow-up in included studies ranged from 1month to 5years and in many cases
was inadequate to capture recurrence except in cases of early technical failure.
Emile etal. reported a weighted mean rate of recurrence of full thickness prolapse
following laparoscopic VMR of 2.8% at a median follow-up of 23months [10].
Meta-regression analysis of factors signicantly associated with prolapse recurrence included male gender (SE = 0.018, 95% CI 0.008–0.044, p = 0.008) and
length of mesh (SE=−0.007, 95% CI −0.01 to −0.001, p = 0.025), with shorter
mesh associated with recurrence.
Flynn etal. did not pool or compare recurrence rates for MA, however, a summary of recurrence rates was similar between the two procedures and was overall
very low, less than 10% after both procedures with follow-up ranging from 1month
to 5years [11].
Function andQuality ofLife
In their MA, Bao etal. reported no statistically signicant difference in pre- and
post-operative mean Wexner scores (weight mean difference 0.09, 95% CI
−0.63-0.82, p=0.79) [8]. The pooled laparoscopic cohort had a higher unadjusted
rate of post-operative FI, but this difference was not signicant. In their SR, Emile
etal. reported signicant improvement in pre- versus post-operative FI in majority
of patients undergoing laparoscopic VMR [10]. The weighted mean rate of improvement in FI was 79.3% (95% CI 69.4–89.1, I2=87.8%), and the weighted mean rate
of improvement in constipation was 71% (95% CI 55.2–86.9, I2=91.2%).
Flynn etal. noted that heterogeneity of functional outcome assessment scores
prevented pooling of results [11]. Overall, both groups showed improvements in
Соседние файлы в папке Библиотека им академика М.И. Перельмана
